Key Insights

Highlights

Treatment Research

2 treatments under study, led by Pdac

Research Leaders

6 sponsors active, led by Alibaba DAMO Academy

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06638866Recruiting

AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

Showing all 1 trials

Research Network

Common Treatments

  • Pdac1
  • Pancreatic Precursor Lesions1

Active Sponsors

  • Alibaba DAMO Academy1
  • Central Hospital of Lishui City1
  • People's Hospital of Jingning She Autonomous County1
  • Changhai Hospital1
  • The Second Affiliated Hospital of Jiaxing University1

Top Investigators

Related Conditions

  • Mucinous Cystic Neoplasm1
  • Pancreatic Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Intraductal Papillary Mucinous Neoplasm1

Activity Timeline